Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
atrasentan hydrochloride (3 trials)
bion-1301 (3 trials)
chk336 (1 trial)
Glomerulonephritis, IGA (Phase 3)
Kidney Diseases (Phase 3)
Trials (7 total)
Trial APIs (3 total)